Skip to content
Pharma Observatory a Scientist.com platform

Organization (Industry)

QIAGEN N.V.

ClinicalTrials.gov lists QIAGEN N.V. as lead sponsor of 27 trials, counting the companies grouped under it.

NL Manufacturer CIK 0001015820
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Companies grouped under this page Companies grouped under this page 1 US granted patents US granted patents 1 Manufacturing and distribution sites Manufacturing and distribution sites 2 Latest dated events Latest dated events 302 Companies grouped under this page Companies grouped under this page 1 US granted patents US granted patents 1 Manufacturing and distribution sites Manufacturing and distribution sites 2 Latest dated events Latest dated events 302

Rows recorded per section (log scale)

20 sections measured, none recorded

Logo Unknown author Unknown author, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.

This page covers QIAGEN N.V. and 1 company grouped under it: 27 lead-sponsored trials (0 its own, 27 in the grouped companies) and 16 legal-entity registrations (16 its own, 0 in the grouped companies).

Get the QIAGEN N.V. report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Companies grouped under this page (1)

Companies grouped under this page
Company Lead trials Legal entities
QIAGEN Gaithersburg, Inc 27 0

US granted patents (1)

Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.

US granted patents
US patents granted Granted in the last 5 years Most recent grant
278 28 2025-11-04

Manufacturing and distribution sites (2)

Shown in this order: severity rank then name.

Manufacturing and distribution sites
Facility Location Regulators Member organization
QIAGEN, GMBH HILDEN North Rhine-Westphalia, DE FDA Qiagen (Germany)
QIAGEN Germantown, US FDA Qiagen

Latest dated events (302)

Shown in this order: newest first.

Latest dated events
Date Event Source
2025-11-04 Patent granted Granted US patents (PatentsView / USPTO)
2025-10-09 FDA import refusal FDA enforcement (warning and untitled letters, recalls, inspections, import refusals, debarment)
2025-09-30 Patent granted Granted US patents (PatentsView / USPTO)
2025-07-22 Patent granted Granted US patents (PatentsView / USPTO)
2025-06-17 Patent granted Granted US patents (PatentsView / USPTO)

On Scientist.com

QIAGEN N.V. is listed as a research supplier in the Scientist.com network.

Service areas

Biology

QIAGEN is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA, and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated biomolecules, such as the DNA of a specific virus, visible for subsequent analysis. We have developed and market more than 500 sample and assay products as well as automated solutions for such consumables. The company provides these products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies...

Show the full description

QIAGEN is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA, and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated biomolecules, such as the DNA of a specific virus, visible for subsequent analysis.

We have developed and market more than 500 sample and assay products as well as automated solutions for such consumables. The company provides these products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. QIAGEN's assay technologies include one of the broadest panels of molecular diagnostic tests available worldwide. This panel includes the digene HPV Test, which is regarded as a "gold standard" in testing for high-risk types of human papillomavirus (HPV), the primary cause of cervical cancer, as well as a broad suite of solutions for infectious disease testing and companion diagnostics.

QIAGEN SERVICE CORE - Let us process your samples! Focus on your research goals instead of sample processing. Our complete service for genomic and expression analysis delivers robust and reproducible results. QIAGEN experts use cutting-edge technology that yields superior results for researchers in academic, governmental, and industrial settings. Our offer covers the whole workflow, from sample to result — and we provide the steps individually or as a full service, depending on your needs.

Website
www.qiagen.com/us

Source: Scientist.com supplier network

Not on this page

Checked, with nothing recorded for this organization: related companies not grouped here, disease areas, trials by start year as sponsor or collaborator, active development programs, approved assets, sponsor delivery record, journals published in, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, climate targets, as filed, workforce and board diversity, as filed, organization relationships, clia clinical laboratory certificates, biomarker capability evidence, and biomarkers this organization publishes on.

Work with Qiagen on Scientist.com

For prices, more details, or to contact Qiagen, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.